WebSMC No. 790/12. Thiotepa (Tepadina®) in combination with other chemotherapy as conditioning treatment in adults or children with haematological diseases, or solid tumours prior to haematopoietic stem cell transplantation (July 2012) Not recommended. WebThiotepa has been used intravesically for the treatment of residual tumours and as adjuvant therapy for prophylaxis of superficial bladder cancer. Thiotepa has also been used parenterally in the palliative treatment of …
thiotepa - Medscape Drugs & Diseases
WebMar 28, 2024 · Thiotepa for injection is a cytotoxic drug. Follow applicable special handling and disposal procedures 1. Reconstitution. Reconstitute thiotepa for injection 100 mg with 10 ml of sterile water for injection. Using a syringe fitted with a needle, aseptically withdraw 10 ml of sterile water for injection. Inject the content of the syringe into ... WebThioplex (thiotepa) for Injection, 15 mg/vial (as lyophilized powder) was approved in 1994 for palliation of a variety of neoplastic diseases. In 2001, three generic drug products of Thioplex were approved. Thioplex has since been discontinued. Only one thiotepa drug product (ANDA 075547) is currently available and listed as the reference drug. cs teach myself
Thiotepa: Uses, Interactions, Mechanism of Action
WebFind information on Thiotepa (Tepadina) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF. WebJul 27, 2024 · Thiotepa (brand name: Thioplex) is a chemotherapy drug. Class: Alkylating agent chemotherapy. Cytoxan is another alkylating agent. How it works: Alkylating agents weaken or destroy breast cancer cells by damaging the cells' genetic material. Uses: Thiotepa usually is given in combination with other chemotherapy medicines. WebHow Tepadina (thiotepa) chemotherapy works, side effects, interactions and precautions. Get free tools to track your health. Skip Navigation ... you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online or by phone (1-800-332-1088). cst ead